Austofix is engaged in the development, manufacturing and marketing of innovative orthopaedic implants for both the domestic and international markets. Austofix holds ISO 13485 accreditation and CE approval through both the Therapeutic Goods Administration (TGA) and British Standards Institute (BSI) for a range of Class I to Class III medical devices.
Austofix has recently engaged a new business model moving away from traditional manufacturing to partnering with other Australian businesses, allowing Austofix to concentrate on developing intellectual property in advanced orthopaedic trauma and related products. Austofix also specialises in regulatory affairs, cleaning, packaging and sterilising through a state of the art facility at the Tech Hub within the Thebarton Technology Precinct.
Austofix continually looks to partner with distribution organisations to promote its quality and cost-competitive products internationally. Austofix is also looking to assist medical companies wishing to utilise Australian packaging & sterilisation facilities and its expert knowledge of the stringent regulatory framework.
LBT Innovations is a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories.Read More
Reproductive Health Science (RHS) develops sophisticated novel molecular tools for amplifying DNA and determining the genetic contents of a single cell.Read More
Biosensis specialises in antibodies and reagents for neuroscience, particularly neurotrophins and neurotrophin receptors.Read More
Austofix develops and manufactures innovative orthopaedic implants for both the domestic and international markets.Read More